Green JB, Bethel MA, Armstrong PW, et al
Statistically significant values are shown in bold
Endocr Pract 2019;25:69100 [DOI] [PubMed] [Google Scholar] 7.Rybelsus [prescribing information] Available from Accessed 23 September 2019 8.Byetta [prescribing information] Available from Accessed 30 August 2019 9.Adlyxin [prescribing information] Available from Accessed 30 August 2019 10.Victoza [prescribing information] Available from Accessed 16 September 2019 11.Trulicity [prescribing information] Available from Accessed 30 August 2019 12.Ozempic [prescribing information] Available from Accessed 30 August 2019 13.Bydureon [prescribing information] Available from Accessed 30 August 2019 14.Wick A, Newlin K
Semaglutide is classified as a glucagon-like peptide-1 (GLP-1) agonist, which is an incretin hormone that has a key element in your digestion, appetite, and overall gut health
Let's look at the research: People who took the maximum dose of tirzepatide over 72 weeks lost an average of 21 percent of their body weight, according to data from clinical trials published in The New England Journal of Medicine in 2022
Semaglutide mimics the hormone GLP-1, slowing stomach emptying and reducing appetite